How to Finance a Med Spa Acquisition

From SBA 7(a) loans to private equity roll-up structures, understand every capital option available for acquiring a profitable medical aesthetics business.

Find Med Spa Deals SBA Calculator →

Med spas generating $300K–$1M+ in EBITDA are among the most financeable lower middle market businesses — SBA-eligible, cash-flowing, and increasingly attractive to lenders familiar with the aesthetics sector. Buyers must navigate CPOM compliance, provider dependency risk, and deferred membership liabilities when structuring a deal. The right capital stack accounts for equipment reserves, working capital, and post-close transition risk specific to physician-supervised service businesses.

Financing Options for Med Spa Acquisitions

SBA 7(a) Loan

$500K–$5MPrime + 2.75%–3.5% (variable), approximately 10%–12% current market

The most common financing path for independent med spa acquisitions. SBA 7(a) loans cover up to 90% of the purchase price, making them ideal for buyers acquiring established aesthetics practices with documented EBITDA and a clean compliance history.

Pros

Low equity injection of 10–20% preserves buyer cash for equipment upgrades and working capital post-close
10-year repayment term keeps monthly debt service manageable relative to med spa cash flow
Seller notes of 5–10% are allowed and count toward equity injection, reducing out-of-pocket requirements

Cons

×Underwriters will scrutinize provider concentration risk — single-injector businesses face loan approval challenges
×Deferred revenue liabilities from pre-sold packages and memberships can reduce lender's view of true EBITDA
×CPOM-compliant MSA structures require experienced SBA lenders familiar with healthcare deal structuring

Seller Financing

$150K–$1M seller note6%–8% fixed, interest-only or fully amortizing over 3–5 years

Owner carries a portion of the purchase price, typically 10–30%, as a subordinated note. Common in med spa deals where valuation gaps exist or buyers need to bridge physician licensing and transition risk during a 12–24 month earnout period.

Pros

Aligns seller incentives with a smooth provider and patient relationship transition post-close
Reduces third-party capital required and can satisfy SBA equity injection requirements
Flexible structuring — payments can be deferred 6–12 months during the buyer's ramp-up period

Cons

×Seller assumes credit risk if the buyer loses key injectors or membership revenue declines post-close
×Subordinated to SBA debt, limiting seller's recourse if the business underperforms
×Sellers nearing retirement may resist long note terms that delay full liquidity realization

Private Equity / Roll-Up Platform Capital

$1M–$5M+ enterprise value transactionsEquity-based — no fixed interest rate; IRR targets of 20%–30% over a 4–6 year hold period

PE-backed aesthetics platforms acquire med spas using equity capital, management rollover, and earnouts tied to EBITDA growth. Sellers retain 15–25% equity, participate in platform upside, and transition into a supported operational role within a multi-location network.

Pros

Sellers receive significant upfront liquidity plus a second bite of the apple through rollover equity in the platform
Platform provides operational infrastructure — marketing, compliance, billing, and equipment procurement at scale
Earnout structures reward sellers who stay engaged and grow EBITDA post-acquisition

Cons

×Sellers give up full autonomy — clinical and business decisions are subject to platform standards and oversight
×Rollover equity is illiquid until a future platform exit, which may be 5–7 years away
×PE buyers apply rigorous due diligence on CPOM structure, EBITDA quality, and provider contracts, extending timelines

Sample Capital Stack

$2,500,000 (med spa with $550K EBITDA, 4.5x multiple)

Purchase Price

Approximately $23,500/month combined debt service on SBA loan at 11.5% over 10 years plus seller note

Monthly Service

1.38x DSCR — comfortably above the SBA minimum 1.25x threshold, with $550K EBITDA supporting full debt service

DSCR

SBA 7(a) loan: $2,125,000 (85%) | Seller note: $125,000 (5%) | Buyer equity injection: $250,000 (10%)

Model your own deal structure →

Lender Tips for Med Spa Acquisitions

1Choose an SBA lender with documented healthcare or medical aesthetics deal experience — CPOM-compliant MSA structures confuse general business lenders and cause unnecessary delays.
2Document EBITDA with a clear add-back schedule that separates owner compensation, personal expenses, and one-time costs from normalized cash flow — lenders will recast aggressively.
3Prepare a provider dependency analysis showing that no single injector drives more than 30–40% of revenue — high concentration is the fastest way to trigger a loan decline.
4Quantify the deferred revenue liability from pre-sold packages and memberships upfront — lenders treat this as a post-close cash obligation and will factor it into working capital requirements.

Frequently Asked Questions

Are med spa acquisitions SBA loan eligible?

Yes — most med spas are SBA 7(a) eligible as operating businesses with documented EBITDA. Lenders evaluate provider dependency, CPOM compliance structure, and deferred revenue liabilities as key underwriting factors specific to the aesthetics industry.

How does corporate practice of medicine (CPOM) law affect financing?

In CPOM states, the business entity cannot employ physicians directly. Acquisitions are typically structured as an asset purchase with a management services agreement separating the business and medical entities — experienced healthcare lenders understand and accommodate this structure.

What EBITDA multiple should I expect to finance for a med spa?

SBA lenders typically finance acquisitions up to 4.5x–5.5x EBITDA for well-documented med spas with diversified revenue, 200+ active members, and no single-provider dependency. Owner-injector businesses trade at lower multiples and face tighter lender scrutiny.

Can deferred revenue from memberships and packages affect my loan approval?

Yes — lenders treat outstanding package and membership obligations as post-close liabilities the buyer must honor without incremental revenue. Buyers should quantify this liability during due diligence and request a working capital line or price adjustment to cover it.

More Med Spa Guides

Buy a Med Spa Business →Valuation Guide →SBA Loan Guide →Deal Structure →Common Mistakes →SBA Calculator →Deal Structure Builder →

Ready to finance your Med Spa acquisition?

DealFlow OS surfaces acquisition targets and helps you structure the deal. Free to join.

Start finding deals — free

No credit card required